Canine Pilot Study Update
Over the past 18 months, the team at Immunolight, along with physicians, veterinarians, scientists and support personnel from the departments of Radiation Oncology at NCSU’s College of Veterinary Medicine and Duke University’s Medical Center, have been conducting a groundbreaking canine pilot study to develop and test Immunolight therapy in the ongoing battle against cancer.
While the pilot study data is being analyzed and prepared for publication, we’re thrilled to share the amazing stories about two of our study subjects and their incredible responses to our treatment!
The first story is about Eliza, a 13-year-old Labrador retriever that was diagnosed with an oral cancer, and was given as little as five weeks to live. As a part of the clinical trial, she was treated nine times over four weeks time with Immunolight therapy. About half-way through the course of her treatment program, Eliza began to experience some extraordinary results …
Read the complete article on the NC State Veterinary Hospital website.
Equally inspiring is the story of Gracie, a 9-year-old dog who had lost her owner to the same type of cancer that afflicted her. Gracie was also a part of the clinical trial program that included nine treatments over the course of four weeks, and she too experienced a very strong response to Immunolight therapy.
Watch the video from ABC Eyewitness News to learn more about Gracie’s incredible response!
We couldn’t be more thrilled to share these incredible stories of two of our successful clinical trial study subjects. Through their participation, we have made significant progress toward moving a potentially promising new therapy ahead in the fight against cancer.
Please stay tuned for future updates. In our next post, we’ll share the details of our ongoing recruitment efforts for our Phase II canine studies.